Anticonvulsant properties of cannabidiol.
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D001831:Body Temperature / Q000187:drug effects; D002188:Cannabis / Q000494:pharmacology*; D003080:Cold Temperature; D013759:Dronabinol / Q000494:pharmacology; D004347:Drug Interactions; D004357:Drug Synergism; D004597:Electroshock; D006614:Hindlimb / Q000187:drug effects; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D010634:Phenobarbital / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D013696:Temperature; D013997:Time Factors
D000927:Anticonvulsants; D010672:Phenytoin; D013759:Dronabinol; D010433:Pentylenetetrazole; D010634:Phenobarbital